(Q50613976)

16 March 2018

title

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease (English)

1 reference

16 March 2018

0 references

1 reference

1 reference

16 March 2018

Richard Mayeux

object named as

R Mayeux

1 reference

16 March 2018

K Marder

1 reference

16 March 2018

Ming-Xin Tang

object named as

M X Tang

1 reference

16 March 2018

author name string

D Jacobs

1 reference

16 March 2018

P Schofield

1 reference

16 March 2018

B Gurland

1 reference

16 March 2018

H Andrews

1 reference

16 March 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

16 March 2018

published in

The Lancet

1 reference

16 March 2018

volume

348

1 reference

16 March 2018

issue

9025

1 reference

16 March 2018

page(s)

429-432

1 reference

16 March 2018

Reduced mortality associated with long-term postmenopausal estrogen therapy.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Epidemiology of clinically diagnosed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen deficiency and risk of Alzheimer's disease in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Senile dementia-Alzheimer's type and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Age-specific incidence of Alzheimer's disease in a community population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

A case-control study of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Presumptive Estrogen Target Neurons Express mRNAs for both the Neurotrophins and Neurotrophin Receptors: A Basis for Potential Developmental Interactions of Estrogen with the Neurotrophins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Clinical application of apolipoprotein E genotyping to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903356-9

7 January 2021

10.1016/S0140-6736(96)03356-9

Identifiers

DOI

1 reference

16 March 2018

1 reference

16 March 2018